Cardioxane (Dexrazoxane Vials) 500 mg

Cardioxane (dexrazoxane) is a cardioprotective agent used to reduce heart damage from certain chemotherapy drugs. Available as 500 mg vials for injection, it helps protect the heart during cancer treatment. This overview covers key uses, effects, and safety notes. buy Cardioxane online safely.

Strength

500 mg

Manufacturer / TM Owner

Clinigen Healthcare Ltd.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Cardioxane is primarily used to protect the heart from damage caused by anthracycline chemotherapy, such as doxorubicin. It is indicated for patients receiving high doses of these medications to reduce the risk of cardiotoxicity. The drug works by helping to prevent oxidative stress in heart tissue. It is not a treatment for cancer itself but supports heart health during chemotherapy.

Side Effects

Cardioxane may help maintain normal heart function in patients undergoing chemotherapy with anthracyclines. Some users report reduced fatigue or improved tolerance to treatment. It does not cure heart conditions but may lessen the impact of chemotherapy-related cardiac effects. Effects vary by individual and treatment plan.

Precautions & Warnings

Cardioxane should only be administered under medical supervision by healthcare professionals. Patients with kidney or liver issues may require adjusted dosing or monitoring. It is not recommended for use in children or pregnant women unless clearly necessary. Always inform your doctor of all medications and health conditions before use.

Avoid Interactions

Cardioxane may interact with other chemotherapy drugs, particularly those that affect the heart. Combining it with certain immunosuppressants or other cardiotoxic agents could increase risks. Alcohol and herbal supplements may also affect its efficacy or safety. Always disclose all medications to your healthcare provider.

References

Frequently Asked Questions

Cardioxane is used to reduce heart damage in patients receiving anthracycline chemotherapy.

It is given as an intravenous injection by a healthcare professional.

Cardioxane is available by prescription only and should be purchased from licensed pharmacies.

Common effects may include nausea, fatigue, or low blood cell counts.

It is not typically recommended for use during pregnancy unless benefits outweigh risks.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.